Hi All, Just to let you know that Mallinckrodt had updated MNK-6106 study record by delaying the clinical results by 3 months; the clinical trial completion date was originally scheduled on 7/30/2019 is now moved to 10/30/2019.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.